The epidemiology of primary liver cancer is reviewed in relation to associated lesions, e.g., cirrhosis, chronic hepatitis. Little data are available to permit evaluation of the frequency of many preneoplastic and precirrhotic lesions which per se carry a low mortality. The proportion of cirrhotic livers in which primary cancer develops varies between countries due to etiological differences. The major factors suspected of causing cirrhosis and cancer in man are: i) hepatitis B, ii) aflatoxin, and iii) alcohol. There is a miscellaneous group of hepatoproliferative disorders due to a wide range of agents which form a small proportion of the total liver problem in industrial and non-industrial states. In contrast to rodents, few liver carcinomas are related to industrial or occupational factors, apart from an association with alcoholism and low socioeconomic class. Data on benign hepatocellular proliferative lesions are inadequate, apart from steroid-induced adenomas. In contrast to rodent studies, primary liver cancers have not been associated in man with enzyme inducers, such as pesticides or drugs. In conclusion, apart from aflatoxin and hepatitis 8, it has proven difficult to make valid comparisons between experimental models and human liver cancer and disease except in relation to morphological pathogenetic pathways. This discrepancy between high frequency or experimental carcinogens identified in rodents and the rarity of demonstrating similar effects due to chemical exposures in man merits further consideration.
The biology of primary carcinoma of the liver in humans is of interest to the toxicological pathologist for several reasons.
1. The incidence of this tumor shows marked geographic variations, which are almost certainly dependent on the environment.
2. There is considerable information on the etiology of this cancer, in both industrial and non-industrial states. 3. Since liver tumors are frequently induced in experimental animals and are relatively homogeneous, they lend themselves to comparative morphological and biochemical studies. Further, experimental hepatomas, benign or malignant, produced by chemical agents are frequently regarded as an index of potential carcinogenicity in humans, not only for the liver, but also for other organs. Thus, a failure to demonstrate etiological comparability for man and animals has significant implications for the methodology of interspecies extrapolation. This paper will be largely based on historical developments on the pathogenesis of liver Presented at the International Symposium of the Society of Toxicologic Pathologists, Reston, Virginia, May 10-12, 1982. carcinoma in humans as an adjunct to today's discussion. No attempt will be made to discuss in depth the vast literature on the biochemistry, and the comparative pathology of human and animal tumors, which have been the subject of numerous recent reviews.
Geographic Patterns of Primary Liver Cancer
The types and patterns of hepatic tumors encountered in clinical practice depend both on geographic location and age of patients. Benign tumors, as distinct from neoplastic and hyperplastic nodules, are generally rare diseases in all age groups and geographic locations. In children, primary malignant tumors (nephroblastomas) are rare and do not show geographical variations. Although the bile duct type tumor shows a marked increase in frequency in some parts of Asia, the problem of primary liver cancer in man is predominantly that of liver cell carcinoma and the present comments will largely be directed to this tumor.
Liver Cell Carcinoma
Few tumors show much wider variation in geographic distribution than liver cell carci-121 TOXICOLOGIC PATHOLOGY noma (1, 2) . In many portions of the world, including North, Central and South America, Canada, most of Europe, the U.S.S.R. and Australia, the tumor is comparatively rare with certain exceptions. Standardized incidence rates tend to be under 5 per 100,000. In contrast, liver cell carcinoma occurs with increased frequency in Africa, south of the Sahara, parts of Southeast Asia and the Pacific Islands.
The tumor occurs widely in sub-Sahara Africa, where it probably affects nearly all indigenous communities. It is most prevalent in southern Africa and the highest incidence is found in Mozambique, where the rates are markedly higher than that seen in parts of the United States and Europe, and 15 times higher than in South Africa (1) (2) (3) (4) . There is some evidence that the frequency may be decreasing in Southern Africa based on reports from gold miners in Johannesburg (3) . In contrast, no increase in the tumor has been reported in the white and Indian populations in this area. Furthermore, no increase in liver cell carcinoma has been reported in North America's black population: this study was of interest in that it was the first carried out to demonstrate the effects of migration on human cancer.
In southern Africa, the tumor develops at a relatively young age. The peak incidence is in the third to fifth decade, however, cases of tumor are found in the second decade (1, 4) .
The distribution of primary carcinoma in Asia tends to show considerable similarities to that seen in southern Africa. However, the increase occurs at a somewhat later age and there may be significant variations between a number of local groups living within the same community, as in Singapore, where it was reported to be more common in immigrants from mainland China, a difference which has since largely disappeared. The disease is very common in mainland China around Canton and Shanghai. It is also increasing in Taiwan.
In parts of Southeast Asia and south China a high frequency of bile duct carcinogenesis (1) associated with clonorchus sinensis has long been recognized, but seems to be disappearing with control of the parasite.
Liver-cancer is comparatively rare in North America and Europe (2) . However, recent studies in Geneva, Switzerland, show a relatively high rate in males (10 per 100,000), which is similar to the incidence in Kenya. No increase is found in females. Again, the increased frequency is largely seen in older age groups. Similar increases were reported in Greece.
There is no correlation between a high incidence of primary non-alcohol related liver cancer and cancer incidence at other sites (2) , in contrast to studies in rodents where hepatocarcinogens have been shown to affect several organs (5) .
Sex Ratios: Liver cell carcinoma occurs predominantly in males, with very high ratios of 10 to 1. Female rates in areas of high liver cell carcinoma are never higher than in males. It should be noted that there are variations in the sex ratio in rodents and very high rates may be found, for example, in female mice.
Histopathology
There are numerous studies on the classification of liver cell carcinoma. In brief, carcinomas are broadly classified as liver cell type and bile duct type, and sometimes mixtures of the two. Classically, liver cell carcinoma shows a wide range of morphological patterns, which have been given individual names, but as yet these have not been related to specific etiological factors. The increase in liver cancer in Africa and Asia is essentially due to an increase in liver cell carcinoma, but there is no basic morphological difference between these high and the low incidence area in North America, despite the wide variation in cirrhosis morphology. The rare embryonal carcinoma of children may be only epithelial or it may contain mesenchymal elements. Geographic variations have not been demonstrated, but the tumor is found in association with various congential abnormalities. From a pathological point of view, there are considerable similarities between rodent and human tumors.
Clinical Presentation
Liver cell carcinoma seems to occur in two major forms which probably reflect different etiological hazards. In the industrial western world, this tumor is either rare or uncommon, occurs predominantly in elderly people, has a male predominance and almost always arises as a complication of long-standing cirrhosis. It is not frequently associated with a positive alpha-fetoprotein test. The onset tends to be insidious. In contrast, in Africa and the Far East it is extremely common in young adults, and there is a marked male predominance. The tumor arises suddenly in apparently healthy individuals and is less frequently as-sociated with cirrhosis. Such tumors are often alpha-fetoprotein positive (4) (5) (6) (7) .
Relationship to Cirrhosis
In man, a high proportion of liver cell carcinomas arise in cirrhotic livers. It would appear, however, that nodular hyperplasia in cirrhosis is not a sufficient stimulus alone for neoplasis, since there is a wide variation in the frequency with which neoplasia develops in cirrhotic livers (1) . In general, the proportion of cirrhotic livers showing malignant change tends to correlate with the frequency of disease, especially in the younger age groups. Unfortunately due to semantic variations in classification, it is unknown whether carcinoma arises with equal frequency in the same morphological type of cirrhosis in countries of high and low incidence. However, general experience would indicate that carcinoma arises frequently in livers with large macronodules, which tends to be more common in Africa than in Europe and North America (1, 4) . The type and etiology of cirrhosis in these two areas differs. In North America, cirrhosis tends to be related to severe macro nodular cirrhosis which appears to arise from an alcoholic hepatitis. In contrast, in Africa, the type of cirrhosis is believed to be produced by the hepatitis B viral infection (1, 8, 9) . Although the tumor is reported to often occur in non-cirrhotic livers, careful examination usually shows that few livers are completely normal, but that there is often evidence of previous damage. Although statistically tumors arise from hyperplastic nodules morphologically similar to those seen in animals, these are not regarded as neoplastic in man. According to the type of hepatocarcinogen, tumors in rodents mayor may not be associated with cirrhosis. In certain cases, e.g. low doses of aflatoxin, tumors may arise in isolated nodules in livers with no evidence of cirrhosis.
Etiology
Although the etiology of hepatocellular carcinoma in man was unknown, it has been recognized for a long time that probably more than one factor was involved (1, 4, 8, 9) . Further, early evidence from migrant studies confirmed that environmental factors were predominant and that there was no obvious genetic predisposition. This point has been further supported by recent studies on histocompatability antigens, although isolated cases have occurred in low incidence regions with alpha-1 antitrypsin deficiency. However, where large groups have been studied, this has not been found to be a factor (4, 7). Hemochromatosis is associated with an increase in the disease in North America, but no increase has been observed in the heavy siderosis found in southern Africa (1) .
The fact that liver cell carcinoma is not common in highly industrialized states where other causal factors can be implicated, suggests that the tumor is not related to exposure to industrial chemicals per se in an occupational context, although the latter may be linked to cancer at other sites.
Alcohol
In western countries, alcoholic cirrhosis is the most common antecedent, but the questions as to the role of ethanol per se remains unanswered. There is no apparent increase in the incidence of hepatocellular carcinoma occurring in alcoholics without cirrhosis. In these cases, cirrhosis per se appears to be important in determining the increased rate of malignancy, but this is difficult to understand, especially the basic biological differences between a macronodular and micronodular cirrhosis. In Africa and the Far East, where cirrhosis coexists with the liver cell carcinoma, it is virtually always of the rnacronodular type, and there is no evidence that ethanol is important (1, 4, 7) . Such etiological factors as parasite infestation, malnutrition have been largely excluded (4) .
The role of hormones is accepted as a cause in a small number of cases of primary liver carcinoma, and have been both in young women taking contraceptive steroids and occasionally with male hormones (4).
MVCOTOXINS AND VIRUSES
Research workers since the 1950s have been looking for a hypothetical toxic agent that might be involved in primary liver cancer in Africa. In 1960, the role of aflatoxin in experimental primary liver cancer was recognized. However, since the early 50s there was increasing evidence that the origin of the cancer was multi-factorial and more than one causal factor may be involved. Furthermore, since the mid 40s, the possible role of the hepatitis virus had been promulgated. This led to the development of a two-stage theory involving hepatitis associated with malnutrition or Iac-TOXICOLOGIC PATHOLOGY tor X (1). Factor X is now believed to be aflatoxin.
Aflatoxins are toxic metabolites of fungi of which there are several in nature. The fungus is a widespread contaminant in nature Sf) the risk of contamination and exposure to the fungus is found in many countries, especially tropical. Positive correlation has been found between aflatoxin content of the diet in Swaziland, Uganda, Mozambique and Kenya (9) . The highest concentration occurred in Mozambique, which also has the highest incidence of hepatocellular carcinoma. Though the correlation between aflatoxin and liver cell carcinoma is good, proof of cause and effect remains to be established, and there are some discrepancies with data from India. Since 1960 the role of aflatoxin in experimental primary liver cancer in rodents has well been recognized.
For many years the type of cirrhosis in which liver cancer arose in Africa was attributed to hepatitis virus (1, 7, 9) . This has raised the possibility that this virus may be one of the environmental factors related to the tumor. This has been strengthened by the finding of a highly significant set of hepatitis B virus markers, surface antigen and antibody against core antigen in patients with the tumor, compared either with matched controls or the general population (7) (8) (9) (10) (11) . The association holds true in most countries studied so far, though it is greatest in those where the incidence is high. Studies by Kew and others have indicated that chronic carriers of hepatitis B virus have a much greater chance of developing tumors when compared with age, sex and racially matched controls. Similar findings have been made in Taiwan. Strong support has come from studies which have shown the presence of hepatitis B surface core antigens in the cirrhotic liver and in the tumor tissue. In addition, hepatocellular carcinoma has been cultured, which has been shown to secrete hepatitis B surface antigens. The question of whether the virus plays a direct etiological role, oncogenic role, or acts indirectly through the causation of cirrhosis has not been finally decided. Nor has the relationship with aflatoxin. There is some experimental evidence that aflatoxin and hepatitis B may act synergistically. Where hepatitis B virus is acquired in early life, it is more likely to give rise to a chronic carrier state. It has been suggested that against this background chronic exposure to high concentrations of aflatoxin may playa part. The role played by the virus may be therefore, either oncogenic or promotional in effect. Evidence has been produced to indicate that the virus itself may integrate with the host cell DNA. There is no evidence that hepatitis A plays an etiological role and while the situation regarding non-A and non-B cannot be excluded, they only probably account for a very small portion of the problem (4) .
In conclusion, in countries in which primary carcinoma occurrs commonly, HBsAg prevalences between 45 and 66% are usually found in patients, although frequency rates as high as 90% have been reported. Lower prevalences are found in countries with low frequency of liver carcinoma, but still the relative risk of a chronic carrier of hepatitis B virus developing cancer has been estimated to be greater than the population with a high incidence.
General Conclusions
It would appear that there is strong evidence that primary liver cancer in humans is a multi-factorial process. In the African region it is probably related to the combination of a virus and possibly a mycotoxin (aflatoxin); whereas in North America and Europe, ethanol ingestion appears to greater significance. Despite the vast number of industrial compounds identified as hepatocarcinogens in rodents, none have yet been identified as important in humans. Vinyl chloride leads to tumors of the Kupffer cell. In contrast, however, certain benign hepatomas and occasional hepatocellular carcinomas can be induced following eposure to steroid hormones, which show many pathological similarities to those seen in experimental animals produced by non-genotoxic carcinogens (2, (12) (13) (14) .
From the viewpoint of morphology, there is much similarity in the pathogenesis of certain genotoxic carcinogens in man and rodents, i.e. development of dysplasia and hyperplastic nodules, and eventually cancer. Similarly, there are many similarities between development of cancer in choline deficient rodents and that seen in "alcoholic" cirrhosis. It is probable that in both situations similar mechanisms may be involved at the molecular level from a qualitative viewpoint, although quantitatively they may be very different. However, despite these similarities, in man as in rodents primary cancer of the liver represents a wide range of interacting steps, the relative weight attributable to each step possibly being very different in each species. Thus, it is not surprising that the correlation between human and rodent liver cancers may not be good in terms of individual animal hepatocarcinogens. This is illustrated by the relationship between aflatoxin and hepatitis B virus. In fact, it has been difficult to find a suitable model equivalent of the hepatitis carrier state in rodents (15) . Although morphologically there are close similarities between choline deficiency, cirrhosis and cancer induction in rats and post alcoholic cirrhosis and liver cancer in humans, so far it has not been proven possible to induce liver cancer in rodents by ethanol alone. In contrast, there appears to be somewhat greater similarities between the production of solitary benign and malignant nodules in humans, i.e. following steroid therapy. It is not clear to what extent pharmacological or toxic damage is a necessary prerequisite to the induction of neoplasia, this exposure must be at high dose levels. Furthermore, despite widespread eposure of humans to many enzyme-inducing agents, e.g, DDT or phenobarbitol, tumors are not found, which contrasts with the high frequency with which they are found in experimental animals.
The most extensive supportive study on the correlation between neoplasms and other tumors occurring in different species of rodents has been made by Tomatis et al. (16) , but no attempt was made to separate genotoxic and non-genotoxic agents, which may have important implications when considering extrapolation between species.
CONCLUSIONS
Whereas there are many similarities between human and animal liver cancers, from the viewpoint of morphogenesis, and probably basic molecular mechanisms, similarities are much less obvious in terms of common etiology probably due to significant quantitative and possibly qualitative differences between the metabolic capacity of the human versus the animal liver. This suggests prudence in extrapolating from animal model to human disease not only for primary cancer of the liver, but also as in the use of liver carcinoma in animals as a simple index of cancer potential at non-hepatic sites.
